Invention Grant
- Patent Title: Methods for predicting pancreatic cancer treatment response
-
Application No.: US16068772Application Date: 2016-01-13
-
Publication No.: US10760135B2Publication Date: 2020-09-01
- Inventor: Pierre Cordelier , Louis Buscail , Frédéric Lopez
- Applicant: INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) , UNIVERSITÉ PAUL SABATIER TOULOUSE III , CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE
- Applicant Address: FR Paris FR Toulouse FR Toulouse
- Assignee: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE),UNIVERSITE PAUL SABATIER TOULOUSE III,CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE
- Current Assignee: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE),UNIVERSITE PAUL SABATIER TOULOUSE III,CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE
- Current Assignee Address: FR Paris FR Toulouse FR Toulouse
- Agency: W&C IP
- International Application: PCT/IB2016/000099 WO 20160113
- International Announcement: WO2017/122039 WO 20170720
- Main IPC: C07H21/04
- IPC: C07H21/04 ; C12Q1/6886 ; G01N33/574 ; A61P35/00 ; A61K31/7068 ; A61K48/00
Abstract:
The present invention relates to methods for predicting pancreatic cancer treatment response.
Public/Granted literature
- US20190024186A1 METHODS FOR PREDICTING PANCREATIC CANCER TREATMENT RESPONSE Public/Granted day:2019-01-24
Information query
